|
|
|
|
|
Pharmacokinetics of nevirapine in HIV-infected children receiving an adult fixed-dose combination of stavudine, lamivudine and nevirapine. |
2548 |
# |
|
|
|
|
|
Pharmacokinetics of rilpivirine and 24-week outcomes after switching from efavirenz in virologically-suppressed HIV-1-infected adolescents. |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjects |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, Safety and Antiviral Activity of Tenofovir exalidex(TXL), a Novel Prodrug of Tenofovir, Administered as Ascending Multiple Doses to HBV-Infected Subjects: A 28 Day Study Final Analyses |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, safety, and efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) single-tablet regimen in HIV-1-infected children (6 to < 12 years) |
2561 |
# |
|
|
|
|
|
Pharmacokinetics, Safety, and Efficacy of Maraviroc in Treatment-Experienced Pediatric Patients Infected With CCR5-Tropic HIV-1. |
2560 |
# |
|
|
|
|
|
Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial |
2565 |
# |
|
|
|
|
|
Pharmacological and Safety Profile of Dexlansoprazole: A New Proton Pump Inhibitor - Implications for Treatment of Gastroesophageal Reflux Disease in the Asia Pacific Region |
2559 |
# |
|
|
|
|
|
Pharmacological Assessment of Efavirenz Weight-Band Dosing Recommendations in HIV-Infected Thai Children |
2556 |
# |
|
|
|
|
|
PHARMCOKINETICS, SAFETY AND ANTIVIRAL ACTIVITY OF CMX157, A NOVEL PRODRUG OF TENOFOVIR, ADMINISTERED AS ASCENDING MULTIPLE DOSES TO HBV-INFECTED SUBJECTS. |
2560 |
# |
|
|
|
|
|
Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma |
2555 |
# |
|
|
|
|
|
Phase 2 Clinical Trial Results for Bitopertin, an Oral Glycine Transporter 1 Inhibitor, in Patients with Non-Transfusion Dependent Beta-Thalassemia |
2562 |
# |
|
|
|
|
|
Phase 2, open-label study of ceritinib in patients (pts) with advanced non-lung solid tumors and hematological malignancies characterized by genetic abnormalities in anaplastic lymphoma kinase (ALK) using a flexible adaptive design: ASCEND-10 |
2560 |
# |
|
|
|
|
|
Phase 3 KEYNOTE-042 Study: Pembrolizumab vs Platinum-Based Chemotherapy as 1l Therapy for Advanced NSCLC with a PD-L1 TPS >= 1% |
2561 |
# |
|
|
|
|
|
PHASE 3 STUDY OF FRONTLINE RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, AND PREDNISONE PLUS VINCRISTINE (R-CHOP) OR BORTEZOMIB (VR-CAP) IN TRANSPLANTATION-UNSUITABLE MANTLE CELL LYMPHOMA (MCL) PATIENTS |
2557 |
# |
|
|
|
|
|
Phase I Study of Dalteparin in Combination With Sunitinib in Patients With Metastatic Clear Cell Renal Carcinoma |
2560 |
# |
|
|
|
|
|
Phase I study of sunitinib and irinotecan for patients with recurrent malignant glioma |
2554 |
# |
|
|
|
|
|
Phase II clinical trial of Ayurved Siriraj Wattana Recipe for symptomatic relief in patients with osteoarthritis of the knee. |
2555 |
# |
|
|
|
|
|
Phase II Consolidation Chemotherapy With Ifosfamide and Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Cervix Uteri |
2554 |
# |
|
|
|
|
|
Phase II randomized trial comparing sequential first-line everolimus and second-line sunitinib versus first-line sunitinib and second-line everolimus in patients with metastatic renal cell carcinoma. |
2557 |
# |
|
|
|
|
|
Phase II study of adjuvant imatinib mesylate (IM) in patients after resection of primary gastrointestinal stromal tumor (GIST): Efficacy and safety at one year. |
2555 |
# |
|
|
|
|
|
Phase II study of carboplatin and paclitaxel in metastatic and/or recurrent NPC: A multicenter study |
2547 |
# |
|
|
|
|
|
Phase II study of concurrent gemcitabine and radiotherapy in locally advanced stage IIIB cervical carcinoma |
2544 |
# |
|
|
|
|
|
Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma |
2555 |
# |
|
|
|
|
|
Phase II study of the combination of gemcitabine plus carboplatin as neoadjuvant treatment in locally advanced breast cancer |
2553 |
# |
|
|
|
|
|
Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer |
2544 |
# |
|
|
|
|
|
Phase III KEYNOTE-048 study of first-line (1L) pembrolizumab (P) for recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Asia vs non-Asia subgroup (subgrp) analysis |
2562 |
# |
|
|
|
|
|
Phase III study of trifluridine/tipiracil versus placebo in Asian patients with metastatic colorectal cancer (TERRA study): Country subgroup |
2560 |
# |
|
|
|
|
|
Phase III, Open-Label, Randomized Study Comparing Concurrent Gemcitabine Plus Cisplatin and Radiation Followed by Adjuvant Gemcitabine and Cisplatin Versus Concurrent Cisplatin and Radiation in Patients With Stage IIB to IVA Carcinoma of the Cervix |
2554 |
# |
|
|
|
|
|
pHCR: a parallel haplotype configuration reduction algorithm for haplotype interaction analysis. |
2552 |
# |